COVID-19 FDA Issues Revised Guidance on Adverse Event Reporting During a Pandemic Thomas Sullivan May 15, 2020 0 In response to rapidly changing conditions due to the COVID-19 pandemic, the US Food and Drug Administration (“FDA”) published a…
